- Home
- ACTG vs PALI Comparison
ACTG vs PALI Comparison
Compare ACTG & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACTG | PALI |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.1M | 249.2M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ACTG | PALI |
|---|---|---|
| Price | $4.19 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.80 |
| AVG Volume (30 Days) | 119.3K | ★ 2.6M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | 97.06 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,004,000.00 | $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $3.24 | $1.32 |
| 52 Week High | $5.27 | $2.86 |
Technical Indicators
Market Signals| Indicator | ACTG | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 36.88 | 38.31 |
| Support Level | $3.86 | $1.32 |
| Resistance Level | $4.30 | $2.18 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 15.52 | 11.29 |
Price Performance
Historical ComparisonAbout ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.